In the intricate world of In Vitro Fertilisation (IVF), the inclusion of add-ons has stirred considerable controversy. These additional procedures, offered with the intention of enhancing live birth rates, have sparked debates due to limited evidence supporting their efficacy and safety. The VALUE Study, a qualitative exploration, delves into the decision-making process surrounding the use of IVF add-ons, shedding light on the perspectives of both patients and health professionals.
Understanding the Controversy
The backdrop of the VALUE Study centres on the polarizing nature of IVF add-ons. Despite their questionable effectiveness and the financial burden they place on patients, these procedures remain popular. The study seeks to address the gaps in understanding by investigating the factors influencing decision-making, sources of information, and concerns regarding safety and effectiveness.
The VALUE Study employs a qualitative, semi-structured interview approach, employing inductive thematic analysis of anonymized transcriptions. Participants, comprising patients (n=25) and health professionals, including embryologists (n=25) and clinicians (n=24), were recruited from diverse clinical settings in the UK and Australia, encompassing both public and private sectors.
The VALUE Study brings to light the nuanced dynamics between patients and professionals in the realm of IVF add-ons. While patients value autonomy in decision-making, professionals stress the critical importance of informed consent. Bridging the gap in discourse is essential, offering an opportunity to enhance the quality of communication between these two crucial stakeholders. As the debate on IVF add-ons continues, the study suggests that a more informed and collaborative approach could pave the way for improved patient outcomes in assisted reproductive technologies.
Read more here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373702/
Citation: Armstrong S, Vaughan E, Lensen S, Caughey L, Farquhar C, Pacey A, Balen M, Peate M, Wainwright E. Patient and professional perspectives about using in vitro fertilisation add-ons in the UK and Australia: a qualitative study. BMJ Open
Acknowledgements: ChatGPT was used to generate this content